Daridorexant
Daridorexant is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including QUVIVIQ. Available dosage form: tablet, film coated.
Drug Details
- Generic Name
- Daridorexant
- Brand Names
- QUVIVIQ
- Application Number
- NDA214985
- Sponsor
- Idorsia Pharmaceuticals Ltd
- NDC Codes
- 2
- Dosage Forms
- TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- DARIDOREXANT
Indications and Usage
1 INDICATIONS AND USAGE QUVIVIQ is indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance [see Clinical Studies (14.1) ] . QUVIVIQ is an orexin receptor antagonist indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance. ( 1 )